Pharma and large biotech companies at Meeting on the Mesa 2026
28 pharma and large biotech companies are at Meeting on the Mesa 2026 — 13 presentations on the program. Most represented: Astellas (1 on the program), Bristol Myers Squibb (2 on the program), AstraZeneca (1 on the program). 13 of them have their own page in this guide.
Focus area
Top represented
Showing 1–19 of 28 organizations
| Organization | Meeting on the Mesa 2026 Attendance |
|---|---|
Astellas Tokyo, Japan | ◆Diamond Sponsor |
Develops and commercializes medicines, with partnering interests in oncology, rare diseases, immunology, cell therapies and gene therapies. | Spotlight Tue, Oct 6 3:30pm Innovation Spotlight company presentation |
Evotec Hamburg, Germany | ◇Bronze Sponsor |
Develops therapeutics and offers integrated iPSC cell therapy development, GMP manufacturing, CMC, regulatory, and clinical services. | Spotlight Mon, Oct 5 12:00pm Innovation Spotlight company presentation |
Bristol Myers Squibb Princeton, NJ | ◆Platinum Sponsor |
Develops and commercializes medicines, including CAR T-cell therapies for cancer and treatments for serious diseases. | Panel Wed, Oct 7 10:45am Panel Wed, Oct 7 8:00am |
BridgeBio Palo Alto, CA | ◇Silver Sponsor |
Develops medicines for genetic conditions through autonomous teams focused on underserved and rare diseases. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
◇Silver Sponsor | |
Develops and commercializes therapies for cancer, transplant-related disease, and rare genetic disorders. | Sponsor In the meeting’s sponsor directory, with no session on the public program |
Sumitomo Pharma America Marlborough, MA | |
Develops and commercializes medicines across oncology, CNS, rare diseases, women’s health, urology, and cell and gene therapy. | Spotlight Tue, Oct 6 3:45pm Innovation Spotlight company presentation |
AstraZeneca Cambridge, United Kingdom | |
Develops and commercializes prescription medicines in oncology, rare diseases, and other biopharmaceutical areas. | |
Eli Lilly Indianapolis, IN | |
Develops and sells prescription medicines across cancer, diabetes, obesity, neuroscience, immunology and other disease areas. | Panel Wed, Oct 7 9:30am |
Gilead Sciences Foster City, CA | |
Develops and commercializes medicines across virology, oncology and inflammation, including cell therapies through Kite. | Panel Wed, Oct 7 10:45am |
Sarepta Cambridge, MA | |
Develops and sells genetic medicines, including gene therapies and RNA-based treatments for rare diseases such as Duchenne muscular dystrophy. | |
Ultragenyx Novato, CA | |
Develops and commercializes therapies, including AAV gene therapies, for rare and ultra-rare genetic diseases. | Panel Wed, Oct 7 3:30pm |
United Therapeutics Corporation Research Triangle Park, NC | |
Develops pulmonary medicines and organ-replacement technologies, including gene-edited pig organs, regenerative medicine, bioprinted organs and ex vivo lung perfusion. | Chair Wed, Oct 7 |
Vor Bio Boston, MA | |
Develops telitacicept, a biologic medicine for autoimmune diseases including lupus, myasthenia gravis and Sjögren’s disease. | |
Bayer Leverkusen, Germany | |
Develops pharmaceutical medicines, including cell therapies and gene therapies for neurological, ophthalmic and other serious diseases. | Attending On the meeting’s published attendee list |
Bracco Milan, Italy | |
Makes diagnostic imaging pharmaceuticals, contrast agents, molecular imaging tracers, medical devices and related healthcare services. | Attending On the meeting’s published attendee list |
Chiesi USA Cary, NC | |
Develops and commercializes specialty medicines for hospital care, rare diseases, neonatology, critical care and respiratory conditions. | Attending On the meeting’s published attendee list |
CJ America Los Angeles, CA | |
Operates CJ’s American businesses, including biotechnology, food, logistics and entertainment subsidiaries. | Attending On the meeting’s published attendee list |
CJ Cheiljedang Seoul, South Korea | |
Makes food ingredients, pharmaceuticals, and biotechnology products through fermentation and other bio-based manufacturing. | Attending On the meeting’s published attendee list |
Genentech South San Francisco, CA | |
Develops and commercializes prescription medicines for serious diseases, including cancer, neurological, autoimmune and ophthalmic conditions. | Attending On the meeting’s published attendee list |
Instantly find 20 buyers from pharma and large biotech companies
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse Meeting on the Mesa 2026 by
Organization type
Focus area
Everyone
Not affiliated with or endorsed by the Alliance for Regenerative Medicine or the Cell & Gene Meeting on the Mesa. Submit a correction